10余年职称评审 职称论文发表经验- 华文期刊网- 客服热线13182189808, QQ398089779
1、Tian WD#, Li JZ#, Hu SW, Peng XW, Li G, Liu X, Chen HH, Xu X, Li XP*. Proteomic identification of alpha-2-HS-glycoprotein as a plasma biomarker of hypopharyngeal squamous cell carcinoma. Int J Clin Exp Pathol, 2015, 8(8):9021-31. (2014 IF: 1.891)
2、Wang L#, Tian WD#, Xu X, Nie B, Lu J, Liu X, Zhang B, Dong Q, Sunwoo JB, Li G, Li XP*. Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. Cancer, 2014, 120(3):363-72. (2014 IF: 4.889)
3、Liu X#, Luo HN#, Tian WD#, Lu J, Li G, Wang L, Zhang B, Liang BJ, Peng XH, Lin SX, Peng Y, Li XP*. Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol Ther, 2013, 14(12):1133-42. (2014 IF: 3.072)
4、Lu J, Zhao FP, Peng Z, Zhang MW, Lin SX, Liang BJ, Zhang B, Liu X, Wang L, Li G, Tian WD, Peng Y, He ML, Li XP*. EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma. Oncotarget, 2014, 5(22):11319-32. (2014 IF: 6.359)
5、Lu J, Luo H, Liu X, Peng Y, Zhang B, Wang L, Xu X, Peng X, Li G, Tian WD, He ML, Kung H, Li XP*. miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis, 2014, 35(3):554-563. (2014 IF: 5.334)
6、Lu J, Xu X, Liu X, Peng Y, Zhang B, Wang L, Luo H, Peng X, Li G, Tian WD, He M, Li XP*. Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis. Br J Cancer, 2014, 110(2):392-398. (2014 IF: 4.836)
7、Yu L, Lu J, Zhang B, Liu X, Wang L, Li SY, Peng XH, Xu X, Tian WD, Li XP*. miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2. Oncol Lett, 2013, 5(4):1223-1228. (2014 IF: 1.554)
8、Zhao FP, Liu X, Chen XM, Lu J, Yu BL, Tian WD, Wang L, Xu X, Huang HR, Zhang MW, Li G, Li XP*. Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma. Oncol Lett, 2015, 10: 2888-2894. (2014 IF: 1.554)
9、Liu X, Lu J, He ML, Li Z, Zhang B, Zhou LH, Li Q, Li G, Wang L, Tian WD, Peng Y, Li XP*. Antitumor effects of interferon-alpha on cell growth and metastasis in human nasopharyngeal carcinoma. Curr Cancer Drug Targets, 2012, 12(5):561-70. (2014 IF: 3.552)
10、Tian WD, Zeng ZY, Chen FJ, Wu GH, Guo ZM, Zhang Q. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma]. Ai Zheng. 2006 Jan; 25(1):80-4. Chinese. PubMed PMID: 16405756.7: Tian WD, Zeng ZY, Chen FJ, Wu GH, Guo ZM, Zhang Q. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma]. Ai Zheng. 2006 Jan; 25(1):80-4. Chinese. PubMed PMID: 16405756.
田文栋,李湘平,李丹凤,刘雄,林少雄,梁勇. 咽旁间隙良性肿瘤的影像学特征及经口手术进路分析[J]. 临床耳鼻咽喉头颈外科杂志,2010,v.24; No. 28 121:983-986.
田文栋,曾宗渊,于文斌,李湘平. 应用SELDI技术建立下咽鳞癌放疗疗效预测模型[J]. 南方医科大学学报,2010,v.3006:1282-1287.
田文栋,曾宗渊,陈福进,伍国号,郭朱明,张诠. 202例Ⅲ~Ⅳ期喉鳞癌治疗方法评价及生存分析[J]. 癌症,2006,01:80-84.
田文栋,曾宗渊,陈福进,伍国号,郭朱明,李浩. 喉咽鳞癌不同治疗方案对喉功能保留及预后的影响[J]. 中华肿瘤防治杂志,2007,01:57-59+63.
李军政,田文栋*,刘雄,胡水旺,张宝,李湘平,下咽癌相关血浆肿瘤标志物的蛋白质组学筛选,南方医科大学学报,2013, 08. 1173-1176
李军政;田文栋*;刘雄;胡水旺;张宝;李湘平喉癌患者与健康人血浆蛋白质差异表达谱的建立及质谱分析,临床耳鼻咽喉头颈外科杂志,2013, 14. 771-774
何英,刘小龙,田文栋,陈怀宏,刘贝娜. 超声引导下粗针自动活检技术在颈部肿物确诊中的应用[J]. 临床耳鼻咽喉头颈外科杂志,2009,v.23; No. 24004:185-186.
刘雄,李刚, 李琦, 田文栋, 张威, 陈怀宏, 李湘平. 重组腺相关病毒协同重组腺病毒增强目的基因表达的体内试验[J]. 南方医科大学学报,2011,v.3101:44-48.
李军政, 陈伟南, 张强, 田文栋. 生物羊膜在鼓膜修补术中的应用价值研究[J]. 现代生物医学进展,2012,v.1236:7150-7152.
刘学奎,
曾宗渊, 田文栋, 于文斌, 陈福进. 钛网喉支架重建的动物实验研究[J]. 现代肿瘤医学,2006,09:1067-1069.
邱书奇, 王东, 田文栋, 陈煜, 毕红霞. 微波治疗在耳鼻咽喉科疾病中的应用(附66例报告)[J]. 山西临床医药,1997,06:32-33.
王东, 李同丽, 王林娥, 田文栋, 陈煜, 邢彩霞. 鼻内窥镜手术中微型电刀的应用[J]. 中华耳鼻咽喉科杂志,2000,06:67.
王东,陈煜, 田文栋, 李同丽, 王林娥. 刺入纵隔的左支气管大头针异物三例[J]. 中华耳鼻咽喉科杂志,2002,05:11.
王东,邱书奇,田文栋. 下鼻甲“窦”样结构伴“窦”内息肉一例[J]. 中华耳鼻咽喉科杂志,1998,06:56.
联系方式:0515- 83271735 13182189808
QQ:398089779